Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Metastatic Breast Cancer

Battling Cancer And Social Security

Tammy Summers

One person with cancer details their challenges with fighting for social security while battling a metastatic breast cancer diagnosis.

Waiting (And Waiting...) Is a Part of the Cancer Journey

Martha Carlson

It's not just time spent sitting in the lobby. Waiting is a way of life for people with cancer.

Three Women: Fearful, Daughter, and Angry

Kathy LaTour

Cancer changes us, and often we find new parts of ourselves that help us accomplish new goals in the face of adversity and tragedy.

FDA's Trodelvy Approval a 'Big Win' for Patients with Metastatic Triple-Negative Breast Cancer

Ryan McDonald

The Food and Drug Administration’s recent approval of the first antibody-drug conjugate to treat patients with pretreated metastatic triple-negative breast cancer is a major milestone, according to one expert.

What You Need to Know About the FDA's Approval of Tukysa for HER2-Positive Breast Cancer

Beth Fand Incollingo and Kristi Rosa

The Food and Drug Administration approved the targeted therapy Tukysa as part of a drug combination to treat HER2-positive breast cancer. Here’s what you need to know.

Moving Away from Chemotherapy to Treat HR-Positive/HER2-Negative Metastatic Breast Cancer

Melissa K. Accordino, MD, MS

Looking at new data from the phase 3 PEARL trial, Dr. Melissa K. Accordino discusses how the use of CDK4/6 inhibitors could help patients with HR-positive/HER2-negative metastatic breast cancer move away from chemotherapy.

Finding a Purpose Through Metastatic Breast Cancer

Jessica Skarzynski

In this week’s episode of the “CURE Talks Cancer Podcast” Melissa Surdez discusses her journey with metastatic breast cancer through the COVID-19 Pandemic.

Decision-Making With Cancer During A Pandemic

Martha Carlson

Choosing the best path forward is hard under any circumstance, but today, those decisions are wrought with additional unknowable risks.

Cancer Strengths in the Midst of A Pandemic

Martha Carlson

Survival strategies for her best life help this metastatic cancer patient navigate a new world in the wake of the COVID-19 pandemic.

FDA Approves New Dose of Herceptin Biosimilar

Ryan McDonald

The Food and Drug Administration approved an updated dose of Ontruzant, a biosimilar to Herceptin, for multiple cancer types.

Metastatic Breast Cancer

Sign In